Sign in
8-K

Current Report

Avalo Therapeutics, Inc. Filed Acc 0001628280-19-013104

Material agreement · Acquisition or sale completed · Regulation FD disclosure

  • Item 1.01 Entry into a material definitive agreement
  • Item 2.01 Completion of acquisition or disposition of assets
  • Item 7.01 Regulation FD disclosure

From the SEC's structured data for this filing

Loading a8-kcloseofaytutransaction.htm…